Name: UMIN ID:
Unique ID issued by UMIN | C000000084 |
---|---|
Receipt number | R000000136 |
Scientific Title | Second line chemotherapy consisting of weekly irinotecan and cisplatin for relapsed/first line resistant non-small cell lung carcinoma - phase II study |
Date of disclosure of the study information | 2005/09/01 |
Last modified on | 2009/08/31 08:34:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/08/29 10:21:43 | ||
2 | Update | 2005/08/29 14:08:41 | Interventions/Control_1 Interventions/Control_1 |
|
3 | Update | 2006/03/09 17:12:31 | Primary outcomes Primary outcomes |
|
4 | Update | 2006/03/09 17:22:06 | Recruitment status |
|
5 | Update | 2006/03/09 17:24:45 | Interventions/Control_1 Interventions/Control_1 Target sample size |
|
6 | Update | 2007/03/05 21:51:12 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2009/08/31 08:28:01 | Organization Organization |
|
8 | Update | 2009/08/31 08:34:27 | Recruitment status Publication of results Results Results Other related information Other related information |